Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Bioreactor Design and Operational System01:29

Bioreactor Design and Operational System

Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Scale-Up Processes01:14

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial Ghosts as Innovative Transport Vehicles for Platinum-Based Anticancer Drugs.

ChemMedChem·2026
Same author

Anticoagulant-free preparation of autologous platelet-rich plasma (PRP) / fluid platelet-rich fibrin (f-PRF): a pre-clinical comparative performance study.

Frontiers in pharmacology·2026
Same author

Assessment of lead, cadmium, and mercury levels in the breast milk in Pakistani women.

Environmental science and pollution research international·2023
Same author

Novel Salinomycin-Based Paramagnetic Complexes-First Evaluation of Their Potential Theranostic Properties.

Pharmaceutics·2022
Same author

Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial.

Radiology and oncology·2022
Same author

Engineered Phage Endolysin Eliminates <i>Gardnerella</i> Biofilm without Damaging Beneficial Bacteria in Bacterial Vaginosis Ex Vivo.

Pathogens (Basel, Switzerland)·2021
Same journal

The Saccharomyces cerevisiae SCRaMbLE system and genome minimization.

Bioengineered bugs·2012
Same journal

Saccharomyces cerevisiae in directed evolution: An efficient tool to improve enzymes.

Bioengineered bugs·2012
Same journal

Saccharomyces cerevisiae STR3 and yeast cystathionine β-lyase enzymes: The potential for engineering increased flavor release.

Bioengineered bugs·2012
Same journal

The winemaker's bug: From ancient wisdom to opening new vistas with frontier yeast science.

Bioengineered bugs·2012
Same journal

Frex and FrexH: Indicators of metabolic states in living cells.

Bioengineered bugs·2012
Same journal

H5N1 moratorium: Missing the point.

Bioengineered bugs·2012
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

The MultiBac Protein Complex Production Platform at the EMBL
13:51

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

The Bacterial Ghost platform system: production and applications.

Timo Langemann1, Verena Juliana Koller, Abbas Muhammad

  • 1BIRD-C GmbH and CoKEG, Kritzendorf, Austria.

Bioengineered Bugs
|February 18, 2011
PubMed
Summary
This summary is machine-generated.

Bacterial Ghosts (BGs) are innovative cell envelopes for targeted delivery of vaccines and drugs. These safe, cost-effective carriers enhance immune responses and have broad applications in biotechnology.

Keywords:
E-mediated lysisbacterial ghostsbacterial inactivationdrug carrierfermentationtumor treatmentvaccineswhite biotechnology

More Related Videos

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

Related Experiment Videos

Last Updated: Jun 4, 2026

The MultiBac Protein Complex Production Platform at the EMBL
13:51

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
06:24

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
15:28

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

Area of Science:

  • Biotechnology
  • Vaccinology
  • Drug Delivery

Background:

  • Bacterial Ghosts (BGs) are derived from Gram-negative bacteria, retaining cellular morphology and surface structures.
  • They are devoid of cytoplasmic content, making them safe delivery vehicles.

Purpose of the Study:

  • To introduce the Bacterial Ghost (BG) platform technology for vaccine, drug, and active substance delivery.
  • To highlight BG applications in white biotechnology and their intrinsic adjuvant properties.

Main Methods:

  • BGs are produced via batch fermentation and purified using tangential flow filtration.
  • Residual bacterial DNA is inactivated using staphylococcal nuclease A and/or β-propiolactone for safety.
  • Antigens or drugs can be incorporated into the BG structure or lumen.

Main Results:

  • BGs effectively target antigen-presenting cells, enhancing both humoral and cellular immune responses.
  • Multiple antigens can be combined within a single BG formulation.
  • Purified BGs can be stored long-term as lyophilized products at room temperature.

Conclusions:

  • The BG platform offers a rapid, safe, and cost-effective solution for targeted delivery of vaccines and active agents.
  • BGs are versatile carriers with broad applications in medicine and white biotechnology, including immobilized enzyme carriers.